Detalhe da pesquisa
1.
Genomic imbalances analysis provides new insight into prognostic factors in adult and pediatric T-ALL.
Blood;
2024 Mar 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38518104
2.
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Blood;
2024 Mar 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38452207
3.
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
Blood;
142(21): 1806-1817, 2023 11 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37595275
4.
Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.
Blood;
139(24): 3505-3518, 2022 06 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35316324
5.
The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohort.
Haematologica;
2024 May 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38695126
6.
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.
Am J Hematol;
99(4): 586-595, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38317420
7.
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.
Mol Cancer;
22(1): 12, 2023 01 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36650499
8.
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
Br J Haematol;
200(2): 175-186, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36214090
9.
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study.
Br J Haematol;
201(6): 1116-1124, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37004981
10.
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL.
Blood;
138(19): 1855-1869, 2021 11 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34125178
11.
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
Haematologica;
108(12): 3287-3297, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36891751
12.
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study.
Blood;
136(3): 328-338, 2020 07 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32321172
13.
High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL.
Haematologica;
107(9): 2072-2080, 2022 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35263986
14.
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial.
Haematologica;
107(12): 2859-2869, 2022 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35615931
15.
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory.
Ann Hematol;
101(10): 2241-2255, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36040480
16.
Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study.
Support Care Cancer;
30(6): 5431-5440, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35304631
17.
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients.
Br J Haematol;
194(2): 393-402, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34195988
18.
Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL.
Blood;
141(11): 1353-1358, 2023 03 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36599110
19.
Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia.
Haematologica;
105(6): 1575-1581, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31537687
20.
Dactinomycin in acute myeloid leukemia with NPM1 mutations.
Eur J Haematol;
105(3): 302-307, 2020 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32452083